fluo-3 and rifampin
fluo-3 has been researched along with rifampin in 5 studies
Research
Studies (5)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Cui, Y; Keppler, D; König, J | 1 |
| Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
| Baldes, C; Koenig, P; Kohlbacher, O; Lehr, CM; Lenhof, HP; Neumann, D | 1 |
| Abed, M; Lang, F; Shaik, N; Towhid, ST | 1 |
Other Studies
5 other study(ies) available for fluo-3 and rifampin
| Article | Year |
|---|---|
Vectorial transport by double-transfected cells expressing the human uptake transporter SLC21A8 and the apical export pump ABCC2.
Topics: Animals; Anions; Antibiotics, Antitubercular; Biological Transport; Cells, Cultured; Dogs; Glutathione; Humans; Indicators and Reagents; Membrane Transport Proteins; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Organic Anion Transporters, Sodium-Independent; Recombinant Proteins; Rifampin; Solute Carrier Organic Anion Transporter Family Member 1B3; Sulfobromophthalein; Transfection; Tritium | 2001 |
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship | 2008 |
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
Development of a fluorescence-based assay for screening of modulators of human organic anion transporter 1B3 (OATP1B3).
Topics: Aniline Compounds; Cell Line; Drug Evaluation, Preclinical; Fluorescent Dyes; Humans; Inhibitory Concentration 50; Ketoconazole; Multidrug Resistance-Associated Protein 2; Organic Anion Transporters, Sodium-Independent; Ouabain; Rifampin; Solute Carrier Organic Anion Transporter Family Member 1B3; Transfection; Xanthenes | 2006 |
Stimulation of suicidal death of erythrocytes by rifampicin.
Topics: Aniline Compounds; Antibiotics, Antitubercular; Apoptosis; Calcium; Cell Death; Cell Membrane; Cell Size; Ceramides; Cytosol; Erythrocytes; Flow Cytometry; Hemolysis; Humans; Phosphatidylserines; Rifampin; Xanthenes | 2012 |